Coltene Holding AGCLHLF 68 ROE % is 22.58% as of Dec. 2025, which is 39% above its 10-year median of 16.25. GuruFocus rates CLHLF with a GF Score™ of 68/100 and a GF Value™ of $66.41. The stock has 3 warning signs investors should review. Among 799 Medical Devices & Instruments companies, Coltene Holding AG ranks better than 85.11% on this metric.
The historical rank and industry rank for Coltene Holding AG's ROE % or its related term are showing as below:
CLHLF'
s ROE % Range Over the Past 10 Years
Min: 9.07 Med: 16.25 Max: 32.09
Current: 14.95
During the past 13 years, Coltene Holding AG's highest ROE % was 32.09%. The lowest was 9.07%. And the median was 16.25%.
CLHLF's ROE % is ranked better than 85.11% of 799
companies
in the Medical Devices & Instruments industry
Industry Median: 2.42
vs CLHLF: 14.95
Coltene Holding AG (OTCPK:CLHLF) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Coltene Holding AG ROE % Related Terms
Coltene Holding AG ROE % Historical Data
* Premium members only.
The historical data trend for Coltene Holding AG's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Coltene Holding AG's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Coltene Holding AG ROE % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Coltene Holding AG's ROE % distribution charts can be found below:
* The bar in red indicates where Coltene Holding AG's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
ROE % is displayed in the 30-year financial page.
Coltene Holding AG (CLHLF) has a ROE % of 22.58% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Coltene Holding AG and its competitors. This is 39% above median its historical median of 16.25. Over the past decade, Coltene Holding AG's ROE % has ranged from 9.07 to 32.09. According to the industry distribution chart, Coltene Holding AG ranks #119 out of 799 companies in the Medical Devices & Instruments industry, placing it in the top 14.9%.
Is Coltene Holding AG's ROE % too high?
Coltene Holding AG's current ROE % of 22.58% is 39% above median its 10-year median of 16.25. Over the past 10 years, this metric has ranged from a low of 9.07 to a high of 32.09. The Medical Devices & Instruments industry median ROE % is 2.42. Coltene Holding AG's value of 22.58% is 833.1% above this industry median. Based on the distribution chart, Coltene Holding AG ranks #119 out of 799 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Coltene Holding AG has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Coltene Holding AG's ROE % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Coltene Holding AG ranks #119 out of 799 companies for ROE %. This places Coltene Holding AG in the top 15% of its industry — outperforming the majority of peers. The industry median ROE % is 2.42. Coltene Holding AG's value of 22.58% is 833.1% above this benchmark. Historically, Coltene Holding AG's own ROE % has ranged from 9.07 to 32.09 over the past decade. While the company's 10-year median is 16.25 vs. the industry median of 2.42, Coltene Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Devices & Instruments company?
The median ROE % among Medical Devices & Instruments companies is 2.42, based on 799 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Coltene Holding AG's current ROE % of 22.58% is 833.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Coltene Holding AG and its competitors. For the Medical Devices & Instruments industry, the median ROE % is 2.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Coltene Holding AG's current ROE % is 22.58%, which is 39% above median its own 10-year median of 16.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coltene Holding AG stock overvalued right now?
Coltene Holding AG (CLHLF) has a current ROE % of 22.58%. The stock's GF Value™ is $66.41, compared to a current price of $61.16 — trading 7.9% below its estimated fair value. The current ROE % is 22.58%, which is 39% above median its 10-year median of 16.25 and 833.1% above the Medical Devices & Instruments industry median of 2.42. Coltene Holding AG's overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Coltene Holding AG (CLHLF), the current ROE % is 22.58% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Coltene Holding AG (CLHLF) Overvalued in 2026?
Based on GuruFocus' analysis, Coltene Holding AG stock appears to be undervalued.
The current stock price of $61.16 is trading 7.9% below its estimated GF Value™ of $66.41.
Key valuation signals for CLHLF:
ROE %: 22.58% (39% above median its 10-year median of 16.25)
GF Value™: $66.41 vs. price of $61.16 (7.9% below fair value)
Industry Position: 833.1% above the Medical Devices & Instruments median (#119 of 799)
No single metric tells the full story. See the CLHLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Coltene Holding AG is a manufacturer and distributor of consumables and small devices for dental practices, dental service organisations (DSOs), dental clinics and laboratories, as well as for non-dental niches (e.g., clinics for ophthalmology or podiatry). The Group develops, manufactures, and sells mainly via distribution channels a broad and comprehensive range of disposables, tools, and equipment for dentists and dental laboratories. Geographically, it operates in EMEA, North America, Latin America, and Asia/Oceania, with maximum from North America.
68GF Score
Get the complete analysis for CLHLF
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLHLF has been successfully added to your 
